anticancer/inflammation

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 369 rezilta yo

Anti-inflammatory agent and cancer-preventive agent comprising canolol or prodrug thereof and pharmaceutical, cosmetic and food comprising the same

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND ART An anti-inflammatory agent is a substance that suppresses inflammatory cytokines and/or inflammatory mediators (such as prostaglandins). Aspirin and teprenone are known examples of anti-inflammatory agents. A cancer-preventive agent is a substance that prevents carcinogenesis induced

Peptide and composition containing the same for anti-inflammation, anti-fibrosis, wound healing, and anticancer treatment

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

PRIORITY This application is a National Stage Application based on International PCT Application PCT/KR2016/005529, filed on May 25, 2016, which claims priority to Korean Patent Application No. 10-2015-0073188 filed on May 26, 2015, the disclosures of which are herein incorporated by reference in

8-anilinoimidazopyridines and their use as anti-cancer and/or anti-inflammatory agents

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

FIELD OF THE INVENTION The invention relates to imidazopyridines with anti-cancer activity and more specifically to imidazopyridines which inhibit MEK kinase activity. The invention also relates to methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian

Compositions of combinations of non-covalent DNA binding agents and anti-cancer and/or anti-inflammatory agents and their use in disease treatment

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Throughout this application various publications are referenced. The disclosures of these publications in their entireties are hereby incorporated by reference into this application in order to more fully describe the state of the art to which this invention pertains. FIELD OF THE INVENTION The

Method of preparation and composition of a water soluble extract of the plant species Uncaria for enhancing immune, anti-inflammatory and anti-tumor processes of warm blooded animals

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND AND FIELD OF THE INVENTION 1. Field of the Invention The present invention deals with defining a phytomedicinal water extract preparation of the plant species Uncaria. In this preparation, many of the ingredients leading to non-specific toxic side effects including palability generated

Method of preparation and composition of a water soluble extract of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention deals with defining a phytomedicinal water extract preparation of the plant species Uncaria. In this preparation, many of the ingredients leading to non-specific toxic side effects including palpability generated from the

Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-.alpha.-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND OF THE INVENTION I. Field of the Invention The present application relates to a group of disubstituted and trisubstituted .alpha.-L-xylo-2-hexulofuranoses not previously disclosed, and having anti-inflammatory and anti-proliferative properties to a degree far exceeding those of previously

Extract of Phaleria macrocarpa as an antineoplastic, anti-inflammatory and antiangiogenic agent

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

FIELD OF THE INVENTION The present invention relates to a herbal extract of the plant of Phaleria macrocarpa, and include the extraction method and description of the biological activities of such extract which include antineoplasia, anti-inflammation, and antiangiogenesis. BACKGROUND OF THE

Substance having antitumor/anti-inflammatory activity

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

TECHNICAL FIELD The present invention relates to novel compounds which are useful as active ingredients of medicaments such as antitumor agents and anti-inflammatory agents. BACKGROUND ART Most anticancer agents clinically used at present have problems such as appearance of cancer cells with

Bisbenzisoselenazolonyl derivatives having antineoplastic, anti-inflammatory and antithrombotic activities as well as their use

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

FIELD OF THE INVENTION The present invention relates to new benzisoselenazolonyl derivatives having antineoplastic, anti-inflammatory and antithrombotic activities as well as their use. Also, the present invention relates to a pharmaceutical composition comprising the benzisoselenazolonyl

Anti-tumor and anti-inflammatory dicinnamoyl-glycerol esters and their analogues

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to anti-cancer drug and, more particularly, to synthetic dicinnamate compounds and their analogues that exhibit anti-tumor activity and/or an anti-inflammatory activity, that has beneficial activity principally in

Bovine excretion extracts having anticancer and anti-inflammatory activity and process for preparing the same

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

TECHNICAL FIELD The present invention relates to bovine excretion extracts and a process for preparing the same. More specifically, the present invention relates to bovine excretion extracts having not only anticancer activity by potent inhibition of cell proliferation and by anti-oxidation but also

Anti-tumor and anti-inflammatory extracts of plant biomass and their uses

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a therapeutic extract derived from plant biomass for use in regressing cancerous tumors and/or for anti-inflammatory effect and, specifically, to a pharmacologically active compound extracted from the indigenous

Metabolically inert anti-inflammatory and anti-tumor antifolates

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

FIELD OF INVENTION This invention relates to folic acid antagonists that are metabolically inert exhibiting a high level of anti-inflammatory and anti-tumor activity. Metabolically inert classical antifolates are new and therefore they exhibit unexpected biological properties such as those recited

N-adamant-1-y1-N1-[4-chlorobenzothiazol-2-y1] urea useful in the treatment of inflammation and as an anticancer radiosensitizing agent

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

FIELD OF THE INVENTION This invention relates generally to N-adamant-1-yl-N'-[4-chlorobenzothiazol-2-yl] urea, pharmaceutical compositions comprising the same, and methods of using the same in the treatment of inflammation and as an anticancer radiosensitizing agent. BACKGROUND OF THE INVENTION The

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye